ProKidney Corp.
PROK
$1.67
-$0.04-2.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.44% | 3.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.44% | 3.69% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.44% | 3.69% | |||
| SG&A Expenses | -3.74% | 1.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.64% | 19.45% | |||
| Operating Income | 1.65% | -19.54% | |||
| Income Before Tax | -0.43% | -20.28% | |||
| Income Tax Expenses | -- | -383.04% | |||
| Earnings from Continuing Operations | -4.33% | -13.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 4.45% | 11.60% | |||
| Net Income | -4.19% | -16.77% | |||
| EBIT | 1.65% | -19.54% | |||
| EBITDA | 1.32% | -19.98% | |||
| EPS Basic | -3.52% | -11.80% | |||
| Normalized Basic EPS | 20.99% | -96.74% | |||
| EPS Diluted | -3.52% | -11.80% | |||
| Normalized Diluted EPS | 20.99% | -96.74% | |||
| Average Basic Shares Outstanding | 0.65% | 4.45% | |||
| Average Diluted Shares Outstanding | 0.65% | 4.45% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||